How Old is Too Old? Closure of Patent Foramen Ovale in Older Patients
Percutaneous closure of a patent foramen ovale (PFO) reduces the risk of recurrent cryptogenic stroke specifically in younger patients. The three randomized controlled trials that led to the widespread adoption of PFO closure excluded patients over the age of 60 years. Older patients frequently have...
Saved in:
| Main Authors: | Carlos Vazquez-Sosa, Stacey D Clegg, James C Blankenship |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Radcliffe Medical Media
2021-10-01
|
| Series: | US Cardiology Review |
| Online Access: | https://www.uscjournal.com/articleindex/usc.2020.40 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Is the patent foramen ovale closure the best option?
by: Viviane Flumignan Zetola, et al.
Published: (2012-12-01) -
Clinical efficacy of percutaneous closure of patent foramen ovale in children diagnosed with migraine
by: Yakun Wang, et al.
Published: (2025-06-01) -
The quest for the identification of pathogenic patent foramen ovale
by: Sebastián Francisco Ameriso
Published: (2021-10-01) -
Atrial fibrillation as a complication of endovascular patent foramen ovale closure: a clinical trial
by: A. S. Tereshchenko, et al.
Published: (2024-12-01) -
Prophylactic antibiotic therapy during endovascular closure of patent foramen ovale: a clinical study
by: A. S. Tereshchenko, et al.
Published: (2024-10-01)